Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Peter MD
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict52/ 100
Grade C · #388Peter MD
A physician-prescribed telehealth brand with tiered semaglutide pricing and a discounted tirzepatide first month — restrictions vary by treatment, excluding several states, and its own marketing page understates them.
Visit Peter MDThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 52/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Peter MD still earns its place — patients outside the excluded states who want tiered semaglutide pricing or a discounted tirzepatide first month from a physician-founded telehealth brand.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results58
92
Real-world results58
97Price honesty42
97
Price honesty42
96Prescriber access60
96
Prescriber access60
88Formulary choice45
88
Formulary choice45
95Cancellation fairness50
95
Cancellation fairness50
93Member support55
93
Member support55
Price, coverage & features
| Metric | CoreAge Rx | Peter MD |
|---|---|---|
| Verdict Score | 94/100 | 52/100 |
| Grade | A | C |
| Semaglutide | $149/mo | $149/mo first-time, $139/mo returning |
| Tirzepatide | $349/mo | $149 first month, then $249/mo thereafter, billed quarterly |
| Coverage | All 50 states | Most states — excludes AL, ID and up to 5 more depending on treatment |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Peter MD
What we like
- Physician-prescribed telehealth model, founded 2021, headquartered in Miami, FL
- Semaglutide is priced in two published tiers, and returning patients pay less than first-time patients ($139/mo vs $149/mo)
- Tirzepatide's discounted first month ($149) is stated up front rather than buried in fine print
The caveats
- The affiliate program's own disclosed restricted-state list is broader than the customer-facing pricing pages: tirzepatide is additionally excluded in AR, CA, MI, NC and TX beyond the AL/ID the marketing page names, and the two disclosures do not agree
- Tirzepatide's price nearly doubles after the first month, from $149 to $249/mo, billed quarterly
- Semaglutide is sold combined with B12 as "GLP1 + B12," not offered as a standalone prescription
- No oral or sublingual option — injectable only
- Customer reviews are mixed
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients outside the excluded states who want tiered semaglutide pricing or a discounted tirzepatide first month from a physician-founded telehealth brand.
Visit Peter MD Read the full Peter MD review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for Peter MD does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.